Analyst Reco. Theraclion

Equities

Real-time Euronext Paris Other stock markets 13:22:22 07/05/2024 BST			5-day change	1st Jan Change
0.4 ^EUR	+0.25%		+8.99%	+3.09%

03-27	Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	CI

No results for this search